Jean Tardu
2PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Aug 22, 2023
Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical Trial.Laurent Fauchier, Nicolas Lamblin, Jean Tardu
|Apr 20, 2022
Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain.Carlos Escobar Cervantes, Julio Martí-Almor, Alejandro Isidoro Pérez Cabeza
Pageof 1
